Feedback / Questions
BEL512 - Belenos Biosciences
https://www.businesswire.com/news/home/20260910813968/en/Belenos-Announces-Positive-Phase-1b-Interim-Asthma-Results-for-BEL512-a-Long-Acting-TSLPIL-13-Bispecific-Antibody
Sep 10, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next